title: Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome.
abstract: The survival of MDS patients without detectable circulating CFU-GM (median = 188 days) was significantly lower than those in whose peripheral blood CFU-GM were detected (median greater than 1000 days) (p less than 0.01). About half of those with detectable PB-CFU-GM died within 2 yr whilst the remainder survived more than ca 3 yr. There was no significant difference in the distribution of patients having 0-5% and greater than 5% marrow blast cells within the three groups.
authors.affiliation: Department of Haematology, University of Wales College of Medicine, Cardiff, U.K.
authors.forename: G B
authors.initials: GB
authors.lastname: Tennant
authors.forename: A
authors.initials: A
authors.lastname: Jacobs
mesh_terms: D000753:Anemia, Refractory / Q000097:blood / Q000401:mortality*; D000754:Anemia, Refractory, with Excess of Blasts / Q000097:blood / Q000401:mortality*; D006098:Granulocytes / Q000473:pathology*; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006801:Humans; D007958:Leukocyte Count; D008264:Macrophages / Q000473:pathology*; D011379:Prognosis